Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies

Publication date: Available online 13 May 2021Source: Progress in Neuro-Psychopharmacology and Biological PsychiatryAuthor(s): Helena Domin

Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - May 13, 2021 Category: Psychiatry Source Type: research